Top 15. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other dividend kings ...

Shares of AbbVie Inc. ABBV shed 2.78% to $176.46 Wednesday, on what proved to be an all-around positive trading session for ...

AbbVie Inc (ABBV) stock saw a decline, ending the day at $181.5 which represents a decrease of $-0.27 or -0.15% from the prior close of $181.77. The stock opened at $182.28 and touched a low of ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Former AbbVie CEO Richard Gonzalez sold his Hidden Hills home for $21.7 million in the pharma executive’s latest real estate ...

We recently published a list of 12 Most Profitable Pharmaceutical Stocks Right Now. In this article, we are going to take a ...

AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

On Friday, AbbVie Inc (ABBV) stock saw a modest uptick, ending the day at $183.34 which represents a slight increase of $0.26 or 0.14% from the prior close of $183.08. The stock opened at $183.11 and ...

We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...

We recently published a list of 8 Most Undervalued Pot Stocks to Buy According to Analysts. In this article, we are going to ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune ...